On the upside
Hoku Scientific (Nasdaq: HOKU) established a schedule for Solarfun Power Holdings to pay Hoku for supplying Solarfun with polysilicon.
Pharmacyclic (Nasdaq: PCYC) reported upbeat interim results from a Phase 1 study of the company's orally administered Bruton's tyrosine kinase inhibitor PCI-32765.
Television company Belo (NYSE: BLC) said that advertising revenue should show improvement.
